GRO beta Rabbit Polyclonal Antibody

SKU: BT-AP10289

Size:100μL

Background:Produced by activated monocytes and neutrophils and expressed at sites of inflammation. Hematoregulatory chemokine| which| in vitro| suppresses hematopoietic progenitor cell proliferation. GRO-beta(5-73) shows a highly enhanced hematopoietic activity.|online information:CXCL2 entry|pharmaceutical:GRO-beta(5-73) is available under the name Garnocestim as immunomodulator. It is used prior to hematopoietic transplantation for peripheral blood stem cell mobilization and reduction of incidence| duration| and/or severity of chemotherapy induced cytopenias.|PTM:The N-terminal processed form GRO-beta(5-73) is produced by proteolytic cleavage after secretion from bone marrow stromal cells.|Belongs to the intercrine alpha (chemokine CxC) family.|

Research_area:Immunology; Stem cells

Target_protein:CXCL2

applications:WB, ELISA

Reactivity:Human, Rat, Mouse

Clonality:Polyclonal

Clone ID:

Host:Rabbit

Isotype:IgG

Gene Symbol/ Name:GRObeta

Immunogen:The antiserum was produced against synthesized peptide derived from human AMPK alpha around the phosphorylation site of Thr172. AA range:140-189

Storage:-20°C for 1 year

Purification:The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Formulation:Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Concentration:1 mg/ml

Molecular weight(Da):11770

UniProt accession:Human: P19875; Mouse: P10889; Rat: P30348

Synonyms:GROβ; C-X-C motif chemokine 2; Growth-regulated protein beta; Gro-beta; Macrophage inflammatory protein 2-alpha; MIP2-alpha; GRO-beta;5-73; GRO-beta-T; Hematopoietic synergistic factor; HSF; SB-251353;

GeneID:Human: 2920; Mouse: 20310; Rat: 114105